This summer, Mercy Springfield opened a national research protocol that will determine the risk factors and incidence of developing lymphedema following surgery for uterine, cervical or vulvar cancers. Jay Carlson, DO, a Mercy gynecologic oncologist in Springfield, is the National Study Chair of this protocol, sponsored through the National Cancer Institute (NCI) and the Gynecologic Oncology Group. It will involve 1,300 women, and Mercy patients with these malignancies are eligible.
Dr. Carlson is also the National Study Chair in a second NCI protocol, using bioimpedance for lymphedema detection. Mercy patients with vulvar cancer are eligible.
For more about Dr. Carlson’s research protocols, visit this page from the NCI.